Both APS and NPS reduced the activation of NF-κB, ERK-MAPK, and p38-MAPK pathways while NPS also decreased the activation of JNK-MAPK pathway (11). The gene discussed is MAPK1; the disease is autoimmune polyendocrinopathy.